The 1,825-day head start: How to stop a generic without a patent
In the fiercely competitive world of pharmaceuticals, securing a patent is often seen as the ultimate shield—protecting innovation and ensuring market exclusivity. But what happens when a company’s patent strategy hits a wall, and a generic drug threat…
The 1,825-day head start: How to stop a generic without a patent Read Post »
